Home / Health / Millions of Eye Drops Recalled: Are Yours Affected?
Millions of Eye Drops Recalled: Are Yours Affected?
4 Apr
Summary
- 3.1 million bottles of K.C. Pharmaceuticals eye drops were recalled.
- The recall is due to concerns that products may not be sterile.
- No contamination detected, but sterility cannot be guaranteed.
U.S. health regulators have issued a warning regarding a voluntary recall of 3.1 million bottles of eye drops manufactured by K.C. Pharmaceuticals. The affected products, including Artificial Tears and Dry Eye Relief, are sold nationwide under various store brand names. The primary concern is a potential lack of sterility, meaning the products may not be free from bacteria or fungi, though no contamination has been detected.
This recall affects generic eye drops with expiration dates between April 30 and July 31, 2026. The FDA advises consumers to discard any recalled products or return them for a refund. While the immediate risk is low, non-sterile eye drops can lead to serious, sight-threatening infections, as evidenced by past outbreaks linked to contaminated products.
Manufacturers are required to produce sterile products in rigorously controlled environments. Failures in this process, such as facility contamination or defective seals, necessitate recalls to prevent potential harm. Consumers seeking relief for eye dryness should prioritize true artificial tears over redness-reducing drops and consider brand-name products due to a recent trend of generic recalls.
